Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis
Analytical Chemistry · 17.03.2026 · 98 (10) · 7149-7158
DOI: 10.1021/acs.analchem.5c06139 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Analytical Chemistry, online erschienen am 04.03.2026. Verfasst von Francesco Greco und 20 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Toscana Gabriele Monasterio, Pisa 56124, Italy. Hauptthemen laut MEDLINE: Proteomics, Amyloidosis, Heart Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amyloidosis is a heterogeneous group of protein misfolding disorders characterized by the deposition of amyloid fibrils in tissues, which causes progressive organ dysfunction. Among the various forms, cardiac involvement by transthyretin (ATTR) and immunoglobulin light chain (AL) amyloidosis is particularly significant, as it is the main determinant of prognosis and treatment. In clinical practice, tissue biopsy remains crucial for diagnosing amyloidosis. Amyloid histological typing can be performed using antibody-based methods such as immunohistochemistry and immunoelectron microscopy. Mass spectrometry-based bottom-up proteomics has emerged as a powerful alternative, offering precise identification and quantification of amyloidogenic proteins. Despite being regarded as an effective technique for amyloid typing, the application of proteomics remains limited to specialized centers due to its technical complexity and lack of standardization in clinical workflows. This paper describes the current use of proteomics in patients with cardiac amyloidosis, based on the experience of referral centers in the USA and Europe, to provide guidance on improving the technique's reliability and to identify standard practices, challenges, and gaps in the clinical application of amyloidosis typing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fondazione Toscana Gabriele Monasterio, Pisa 56124, Italy.
- Fondazione Pisana per la Scienza ONLUS, San Giuliano Terme 56017, Italy.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55902 United States.
- Centre for Amyloidosis, Division of Medicine, Royal Free Campus, University College London, London NW3 2PF, U.K.
- Division of Cardiology, Oregon Health & Science University, Portland, Oregon 97239, United States.
- Scuola Superiore Sant'Anna, Health Science Interdisciplinary Center, Pisa 56127, Italy.
ORCID-Profile: Francesco Greco, Luca Menichetti, Lidia Ciccone, Julian D Gillmore, Liam Andrew McDonnell
Zitieren
APA
Greco, F., McPhail, E., Canetti, D., Masri, A., Ferrari Chen, Y. F., Menichetti, L., Aimo, A., Franzini, M., Ciccone, L., Pucci, A., Castiglione, V., Limongelli, G., Merlo, M., Sinagra, G., Basso, C., Fontana, M., Gillmore, J. D., McDonnell, L. A., Emdin, M., …, & Vergaro, G. (2026). Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis. Analytical Chemistry, 98(10), 7149-7158. https://doi.org/10.1021/acs.analchem.5c06139
Vancouver
Greco F, McPhail E, Canetti D, Masri A, Ferrari Chen YF, Menichetti L, et al. Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis. Analytical Chemistry. 2026;98(10):7149-7158. doi:10.1021/acs.analchem.5c06139
BibTeX
@article{Greco2026,
author = {Greco, Francesco and McPhail, Ellen and Canetti, Diana and Masri, Ahmad and Ferrari Chen, Yu Fu and Menichetti, Luca and Aimo, Alberto and Franzini, Maria and Ciccone, Lidia and Pucci, Angela and Castiglione, Vincenzo and Limongelli, Giuseppe and Merlo, Marco and Sinagra, Gianfranco and Basso, Cristina and Fontana, Marianna and Gillmore, Julian D and McDonnell, Liam Andrew and Emdin, Michele and Merlini, Giampaolo and Vergaro, Giuseppe},
title = {Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {10},
pages = {7149--7158},
doi = {10.1021/acs.analchem.5c06139}
}
EUVIMED